Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial

Coronary plaques that are prone to rupture and cause adverse cardiac events are characterized by large plaque burden, large lipid content, and thin fibrous caps. Statins can halt the progression of coronary atherosclerosis; however, the effect of the proprotein convertase subtilisin kexin type 9 inh...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	JAMA : the journal of the American Medical Association Ročník 327; číslo 18; s. 1771
Hlavní autori:	Räber, Lorenz, Ueki, Yasushi, Otsuka, Tatsuhiko, Losdat, Sylvain, Häner, Jonas D, Lonborg, Jacob, Fahrni, Gregor, Iglesias, Juan F, van Geuns, Robert-Jan, Ondracek, Anna S, Radu Juul Jensen, Maria D, Zanchin, Christian, Stortecky, Stefan, Spirk, David, Siontis, George C M, Saleh, Lanja, Matter, Christian M, Daemen, Joost, Mach, François, Heg, Dik, Windecker, Stephan, Engstrøm, Thomas, Lang, Irene M, Koskinas, Konstantinos C
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 10.05.2022
Predmet:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Cholesterol, LDL Coronary Artery Disease - complications Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - drug therapy Double-Blind Method Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Male Middle Aged Myocardial Infarction - complications Myocardial Infarction - drug therapy PCSK9 Inhibitors - therapeutic use Plaque, Atherosclerotic - complications Plaque, Atherosclerotic - diagnostic imaging Plaque, Atherosclerotic - drug therapy Treatment Outcome
ISSN:	1538-3598, 1538-3598
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!